The Online Investor
Technology M&A image Technology M&A » By The Online Investor Staff, updated Mon., Sep. 28, 7:00 AM Recent mergers and acquisitions in the Technology M&A category.

Slide #80. Mesa Laboratories, Inc. Amilabo SAS

Acquirer: Mesa Laboratories, Inc. (NASDAQ:MLAB)
Acquiree: Amilabo SAS
Details: Mesa Laboratories, Inc. (Nasdaq:MLAB) (we, us, our, "Mesa" or the "Company") today announced the acquisition of Amilabo SAS ("Amilabo"), a distributor of the Company's biological indicator (BI) products, located near Lyon, France. In this transaction, Mesa acquired all of the outstanding shares of Amilabo.

Mesa Laboratories designs, manufactures, and markets quality control products and services. Co.'s divisions include: Sterilization and Disinfection Control, which provides testing services, along with the manufacture and marketing of biological, chemical and cleaning indicators; Instruments, which designs, manufactures and markets quality control instruments and disposable products; Biopharmaceutical Development, which develops, manufactures, and commercializes automated solutions for protein analysis (immunoassays) and peptide synthesis; and Continuous Monitoring, which designs, develops and markets systems which are used to monitor various environmental parameters.

MLAB SEC Filing Email Alerts Service


Open the MLAB Page at The Online Investor »

Company Name: 
Mesa Laboratories, Inc.
Website: 
www.mesalabs.com
Sector: 
Medical Instruments & Supplies
Number of ETFs Holding MLAB: 
41
Total Market Value Held by ETFs: 
$226.01M
Total Market Capitalization: 
$1.20B
% of Market Cap. Held by ETFs: 
18.90%
 

Open the MLAB Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Strong Buy (4.00 out of 4)
88th percentile
(ranked higher than approx. 88% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Technology M&A - Slide 80 of 100 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2020, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.